GenMark Diagnostics ROA 2010-2019 | GNMK

Current and historical return on assets (ROA) values for GenMark Diagnostics (GNMK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. GenMark Diagnostics ROA for the three months ending March 31, 2019 was -54.05%.
GenMark Diagnostics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-03-31 $-0.05B $0.10B -54.88%
2018-12-31 $-0.05B $0.09B -51.91%
2018-09-30 $-0.05B $0.09B -51.18%
2018-06-30 $-0.06B $0.10B -50.43%
2018-03-31 $-0.06B $0.11B -46.46%
2017-12-31 $-0.06B $0.12B -53.80%
2017-09-30 $-0.06B $0.13B -57.28%
2017-06-30 $-0.06B $0.15B -60.64%
2017-03-31 $-0.05B $0.06B -70.99%
2016-12-31 $-0.05B $0.08B -70.34%
2016-09-30 $-0.05B $0.09B -66.90%
2016-06-30 $-0.05B $0.06B -67.65%
2016-03-31 $-0.05B $0.06B -61.43%
2015-12-31 $-0.04B $0.07B -51.85%
2015-09-30 $-0.04B $0.08B -48.70%
2015-06-30 $-0.04B $0.08B -44.81%
2015-03-31 $-0.04B $0.09B -41.13%
2014-12-31 $-0.04B $0.09B -37.96%
2014-09-30 $-0.04B $0.10B -37.19%
2014-06-30 $-0.04B $0.11B -35.59%
2014-03-31 $-0.04B $0.11B -36.97%
2013-12-31 $-0.03B $0.12B -36.56%
2013-09-30 $-0.03B $0.13B -35.22%
2013-06-30 $-0.02B $0.06B -35.66%
2013-03-31 $-0.02B $0.06B -30.55%
2012-12-31 $-0.02B $0.07B -37.86%
2012-09-30 $-0.02B $0.07B -43.19%
2012-06-30 $-0.02B $0.07B -48.94%
2012-03-31 $-0.02B $0.03B -55.76%
2011-12-31 $-0.02B $0.04B -61.94%
2011-09-30 $-0.02B $0.04B -64.79%
2011-06-30 $-0.02B $0.05B -69.84%
2011-03-31 $-0.02B $0.02B -77.78%
2010-12-31 $-0.02B $0.03B -88.37%
2010-09-30 $-0.02B $0.03B -137.70%
2010-06-30 $-0.02B $0.03B -266.67%
2010-03-31 $-0.02B $0.00B inf%
2009-12-31 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.399B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $106.139B 23.22
Intuitive Surgical (ISRG) United States $55.826B 51.44
Edwards Lifesciences (EW) United States $35.862B 35.83
Fresenius Medical Care AG KGaA (FMS) Germany $23.725B 15.59
IDEXX Laboratories (IDXX) United States $21.454B 56.28
Teleflex (TFX) United States $13.633B 29.54
Hologic (HOLX) United States $12.022B 19.33
ABIOMED (ABMD) United States $11.738B 71.72
Varian Medical Systems (VAR) United States $11.636B 29.68
STERIS (STE) United Kingdom $11.487B 27.77
DexCom (DXCM) United States $10.798B 211.77
Masimo (MASI) United States $7.410B 45.40
Penumbra (PEN) United States $4.780B 202.35
Integra LifeSciences Holdings (IART) United States $4.253B 19.98
Globus Medical (GMED) United States $4.128B 25.74
Wright Medical Group (WMGI) Netherlands $3.943B 781.50
Tandem Diabetes Care (TNDM) United States $3.915B 0.00
LivaNova (LIVN) United Kingdom $3.578B 23.33
Cantel Medical (CMD) United States $2.842B 28.26
Glaukos (GKOS) United States $2.426B 0.00
Integer Holdings (ITGR) United States $2.309B 17.01
AVANOS MEDICAL, INC (AVNS) United States $2.043B 32.33
Nevro (NVRO) United States $1.846B 0.00
ShockWave Medical (SWAV) United States $1.583B 0.00
Inogen (INGN) United States $1.513B 33.49
Silk Road Medical (SILK) United States $1.488B 0.00
OPKO Health (OPK) United States $1.293B 0.00
CryoLife (CRY) United States $1.089B 108.04
Pacific Biosciences Of California (PACB) United States $1.066B 0.00
Accelerate Diagnostics (AXDX) United States $1.039B 0.00
Veracyte (VCYT) United States $1.026B 0.00
Mesa Laboratories (MLAB) United States $0.985B 40.30
ORTHOFIX MEDICAL INC (OFIX) United States $0.978B 28.35
Tactile Systems Technology (TCMD) United States $0.941B 138.78
Luminex (LMNX) United States $0.936B 122.47
Natus Medical (BABY) United States $0.907B 21.00
AxoGen (AXGN) United States $0.844B 0.00
ViewRay (VRAY) United States $0.842B 0.00
Fluidigm (FLDM) United States $0.821B 0.00
Intersect ENT (XENT) United States $0.803B 0.00
AngioDynamics (ANGO) United States $0.710B 24.78
Quotient (QTNT) Switzerland $0.623B 0.00
OrthoPediatrics (KIDS) United States $0.603B 0.00
Corindus Vascular Robotics (CVRS) United States $0.544B 0.00
Si-Bone (SIBN) United States $0.400B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.397B 21.30
Accuray (ARAY) United States $0.343B 0.00
RTI Surgical (RTIX) United States $0.323B 39.73
TransEnterix (TRXC) United States $0.274B 0.00
Neuronetics (STIM) United States $0.273B 0.00
Pulse Biosciences (PLSE) United States $0.269B 0.00
SeaSpine Holdings (SPNE) United States $0.264B 0.00
IRadimed (IRMD) United States $0.245B 46.79
ConforMIS (CFMS) United States $0.233B 0.00
Sientra (SIEN) United States $0.211B 0.00
CRH Medical (CRHM) Canada $0.207B 72.25
Alphatec Holdings (ATEC) United States $0.192B 0.00
Biosig Technologies (BSGM) United States $0.151B 0.00
Ekso Bionics Holdings (EKSO) United States $0.120B 0.00
T2 Biosystems (TTOO) United States $0.112B 0.00
Second Sight Medical Products (EYES) United States $0.102B 0.00
EDAP TMS (EDAP) France $0.100B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Vermillion (VRML) United States $0.092B 0.00
Soliton (SOLY) $0.092B 0.00
Apollo Endosurgery (APEN) United States $0.080B 0.00
Nuvectra (NVTR) United States $0.076B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.067B 0.00
Ra Medical Systems (RMED) United States $0.061B 0.00
Titan Medical (TMDI) Canada $0.059B 0.00
Helius Medical Technologies (HSDT) United States $0.055B 0.00
Electromed (ELMD) United States $0.046B 23.70
Xtant Medical Holdings (XTNT) United States $0.040B 0.00
Neovasc (NVCN) Canada $0.033B 0.00
PAVmed (PAVM) United States $0.032B 0.00
Avinger (AVGR) United States $0.030B 0.00
Viveve Medical (VIVE) United States $0.028B 0.00
DarioHealth (DRIO) Israel $0.028B 0.00
Microbot Medical (MBOT) United States $0.026B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
Atossa Genetics (ATOS) United States $0.025B 0.00
Restoration Robotics (HAIR) United States $0.023B 0.00
Bioanalytical Systems (BASI) United States $0.020B 0.00
Nanovibronix (NAOV) United States $0.019B 0.00
American Shared Hospital Services (AMS) United States $0.017B 18.31
Dynatronics (DYNT) United States $0.015B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.014B 0.00
ReWalk Robotics (RWLK) Israel $0.013B 0.00
OBALON THERPTCS (OBLN) United States $0.009B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
ALCON INC (ALC) $0.000B 0.00